0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-55.04%PremiumJun 21, 2024Expiry Date6.12Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Precision BioSciences Stock Discussion
Precision BioSciences Announces Common Stock Purchase By Members Of Management, Including CEO, For $300,000 In Private Placement
NEWS
PRECISION BIOSCIENCES ANNOUNCES COMMON STOCK PURCHASE BY MEMBERS OF MANAGEMENT FOR $300,000 IN A PRIVATE PLACEMENT
Precision BioSciences Announces Receipt of FDA Fast Track Designation for Ecur-506, Iecure’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (Otc) Deficiency
No comment yet